BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31413078)

  • 1. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
    Lipsett SC; Branda JA; Nigrovic LE
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
    Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
    Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
    J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
    Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
    J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.
    Lipsett SC; Branda JA; McAdam AJ; Vernacchio L; Gordon CD; Gordon CR; Nigrovic LE
    Clin Infect Dis; 2016 Oct; 63(7):922-8. PubMed ID: 27358358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
    Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
    J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
    Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
    Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
    Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
    Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
    Dickeson DJ; Chen SC; Sintchenko VG
    Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
    Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
    Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C6 peptide enzyme immunoassay in Lyme borreliosis serology.
    Rouhiainen M; Pietikäinen A; Kortela E; Kanerva MJ; Oksi J; Hytönen J
    J Microbiol Methods; 2021 Jan; 180():106122. PubMed ID: 33326821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of C6 Enzyme Immunoassay for Lyme Arthritis.
    Nigrovic LE; Bennett JE; Balamuth F; Levas MN; Neville D; Lyons TW; Branda JA; Maulden AB; Lewander D; Garro A;
    Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31836615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
    Sabin AP; Scholze BP; Lovrich SD; Callister SM
    Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.
    Molins CR; Delorey MJ; Sexton C; Schriefer ME
    J Clin Microbiol; 2016 Nov; 54(11):2726-2734. PubMed ID: 27558183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Tier Lyme Disease Serology Test Results Can Vary According to the Specific First-Tier Test Used.
    Maulden AB; Garro AC; Balamuth F; Levas MN; Bennett JE; Neville DN; Branda JA; Nigrovic LE
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):128-133. PubMed ID: 30793167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.